glp 1 agonists uses glp-1_analogs [TUSOM GLP-1 receptor agonists show promise
Description
Neuen BL, Young T, Heerspink HJL et al (2019) SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
Stimulation of gluconeogenesis by long chain fatty acids and glucagon
The subcutaneous route of administration is projected to reach USD 453.72 billion by 2032 from USD 44.21 billion in 2024, at a CAGR of 33.8% during the forecast period
Diabetic kidney disease: a report from an ADA Consensus Conference
Most modern weight-loss drugs work by mimicking natural hormones your gut produces after you eat
Satiety effects of psyllium in healthy volunteers
